Cart 0

Introducing the FIRST and ONLY active verification tool that identifies a patient’s suitability for chronic opioid therapy before you prescribe and reassesses risk and benefit every time you prescribe.

  • The estimated cost of CPD diversion and abuse is $72.5 billion
  • 47,055 drug overdose deaths in 2014
  • The leading cause of injury death in the US is drug overdose
  • The US makes up only 4.6% of the world's population, but consumes 80% of its opioids
  • Nearly 80% of all new heroin users report taking opioids first


Our mission:

To end the opioid misuse epidemic.


By assisting medical practices in creating and implementing a Diversion Control Plan, Sure Med is changing the way education is delivered to doctors and giving them tools to better treat patients and protect themselves from criminal and civil liability. In addition to an initial risk assessment, Sure Med delivers several training sessions including Risks and Recommendations, Healthy Treatment Algorithm and Ongoing Best Practices to ensure your organization has the most up-to-date information in the rapidly changing battle against diversion and misuse.


The DEA requires all practices that prescribe controlled substances to have a plan in place, that helps mitigate the likelihood of pharmaceutical diversion and misuse. Offices must enact certain safeguards to prevent from being an easy target for those who would seek to obtain controlled substances for nonmedical purposes. While the language concerning DEA requirements for a diversion control plan is vague, recent case law shows a radical and clear change in the court's opinion concerning prescriber liability and the need for certain measures to be implemented.


According to the CDC, drug overdose has surpassed motor vehicle accidents and is now the leading cause of injury death in the US. This resurgence in illicit drug use, specifically heroin, is being fueled by widespread, nonmedical use of controlled substances. Current measures aimed at fixing this epidemic have largely been reactive in nature and have had little impact on helping physicians distinguish between medical and nonmedical use of controlled substances in their patient population.


Our internal audit gives your organization visibility into how well your Diversion Control Plan is being implemented. By allowing us to access and audit patient charts, we are able to make meaningful recommendations to ensure your full compliance. This helps to show what you’re doing well and what can be improved upon.


Care Continuity Program

We know time with the patient is limited. We also know that as a prescriber of controlled substances, you are being asked to do more.

Let us help by doing some of the work for you. Our evaluations are based on the most current opioid prescribing guidelines and can be accessed by the patient prior to the office visit. Patients simply log onto the Care Continuity portal, answer some questions and submit their responses. Care Continuity Risk Reports are available in real-time, giving you the information you need to make prudent clinical decisions, when you need it.